ATYR PHARMA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.555 USD | -2.20% |
|
-2.19% | +10.64% |
| 03-15 | RBC Cuts Price Target on aTyr Pharma to $16 From $19, Keeps Outperform Rating, Speculative Risk Qualifier | MT |
| 03-14 | Transcript : ATyr Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 1.770 | 2.020 | 2.450 |
| Spread/Res. | -11.86% | -22.77% | -36.33% |
| Spread/Supp. | -0.64% | +9.86% | +39.29% |
| Support | 1.570 | 1.420 | 1.120 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LIFE Stock
- Charts aTyr Pharma, Inc.
